Muto, A. et al. The transcriptional programme of antibody class switching involves the repressor Bach2. Nature 429, 566-571

Department of Biomedical Chemistry and Leukemia Program Project, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima 734-8551, Japan.
Nature (Impact Factor: 41.46). 07/2004; 429(6991):566-71. DOI: 10.1038/nature02596
Source: PubMed


Activated B cells differentiate to plasma cells to secrete IgM or, after undergoing class switch recombination (CSR), to secrete other classes of immunoglobulins. Diversification of antibody function by CSR is important for humoral immunity. However, it remains unclear how the decision for the bifurcation is made. Bach2 is a B-cell-specific transcription repressor interacting with the small Maf proteins whose expression is high only before the plasma cell stage. Here we show that Bach2 is critical for CSR and somatic hypermutation (SHM) of immunoglobulin genes. Genetic ablation of Bach2 in mice revealed that Bach2 was required for both T-cell-independent and T-cell-dependent IgG responses and SHM. When stimulated in vitro, Bach2-deficient B cells produced IgM, as did wild-type cells, and abundantly expressed Blimp-1 (refs 9, 10) and XBP-1 (ref. 11), critical regulators of the plasmacytic differentiation, indicating that Bach2 was not required for the plasmacytic differentiation itself. However, they failed to undergo efficient CSR. These findings define Bach2 as a key regulator of antibody response and provide an insight into the orchestration of CSR and SHM during plasma cell differentiation.

Download full-text


Available from: Dai Ikebe, Feb 12, 2015
  • Source
    • "Restifo and colleagues very recently reported a novel role of the transcriptional repressor BACH2 in regulating Treg differentiation and decreasing the effector function of Th1 and Th17 cells (123). BACH2 is a known regulator of Blimp-1 in B cells required for class switch recombination; however, its role in T cells was unknown (124). When CD4+ T cells were programed toward an inducible Treg subset (via IL-2 and TGF-β), wild-type cells converted to FoxP3+ Treg cells while Bach2 KO cells differentiated into effector T cells (Figure 6A). "
    [Show abstract] [Hide abstract]
    ABSTRACT: T helper 17 (Th17) cells play a complex and controversial role in tumor immunity and have been found to exhibit a fluctuating identity within the context of cancer. The recent, expanding literature on these cells attests to their puzzling nature, either promoting or suppressing tumor growth depending on the malignancy and course of therapeutic intervention investigated. This review addresses several newly appreciated factors that may help delineate Th17 cells' immunological properties in the context of cancer. Several reports suggest that inflammatory signals induced in the tumor milieu regulate the functional fate and antitumor activity of Th17 cells. Recent findings also point to significant alterations in Th17 cells due to their interplay with regulatory T lymphocytes and cytotoxic CD8(+) T cells within the tumor microenvironment. Finally, an appreciation for the stem cell-like properties of Th17 cells that augment their persistence and activity emerges from recent reports. The impact of these factors on Th17 cells' antitumor efficacy and how these factors may be exploited to improve cancer therapies will be discussed.
    Frontiers in Immunology 06/2014; 5:276. DOI:10.3389/fimmu.2014.00276
  • Source
    • "Mice. Bach2-deficient mice were described previously (Muto et al., 2004). B cell–specific Blimp-1–deficient mice (Shapiro-Shelef et al., 2003) were provided by K. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Pulmonary alveolar proteinosis (PAP) results from a dysfunction of alveolar macrophages (AMs), chiefly due to disruptions in the signaling of granulocyte macrophage colony-stimulating factor (GM-CSF). We found that mice deficient for the B lymphoid transcription repressor BTB and CNC homology 2 (Bach2) developed PAP-like accumulation of surfactant proteins in the lungs. Bach2 was expressed in AMs, and Bach2-deficient AMs showed alterations in lipid handling in comparison with wild-type (WT) cells. Although Bach2-deficient AMs showed a normal expression of the genes involved in the GM-CSF signaling, they showed an altered expression of the genes involved in chemotaxis, lipid metabolism, and alternative M2 macrophage activation with increased expression of Ym1 and arginase-1, and the M2 regulator Irf4. Peritoneal Bach2-deficient macrophages showed increased Ym1 expression when stimulated with interleukin-4. More eosinophils were present in the lung and peritoneal cavity of Bach2-deficient mice compared with WT mice. The PAP-like lesions in Bach2-deficient mice were relieved by WT bone marrow transplantation even after their development, confirming the hematopoietic origin of the lesions. These results indicate that Bach2 is required for the functional maturation of AMs and pulmonary homeostasis, independently of the GM-CSF signaling.
    Journal of Experimental Medicine 10/2013; 210(11). DOI:10.1084/jem.20130028 · 12.52 Impact Factor
  • Source
    • "This gene transcribes the BACH2 protein that has high expression in B cells prior to the plasma cell stage of B cell development (Muto et al., 2004). BACH2 is a critical player in class switch recombination and somatic hypermutation (Muto et al., 2004). Little more is known about the mechanisms by which this association operates. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Ankylosing spondylitis (AS) is a chronic inflammatory arthritis that affects the spine and sacroiliac joints. It causes significant disability and is associated with a number of other features including peripheral arthritis, anterior uveitis, psoriasis and inflammatory bowel disease (IBD). Significant progress has been made in the genetics of AS have in the last five years, leading to new treatments in trial, and major leaps in understanding of the aetiopathogenesis of the disease.
    Molecular Immunology 07/2013; 57(1). DOI:10.1016/j.molimm.2013.06.013 · 2.97 Impact Factor
Show more